C4A and primary biliary cholangitis: On the other hand, the majority of PBC patients have normal, or at least, significant levels of C4 and BA synthesis, and given the central role of the accumulated hepatic BAs in the pathogenesis of PBC [5–7,14], suppressing BA synthesis may provide significant therapeutic benefits.